VIO, LUCIANO
 Distribuzione geografica
Continente #
NA - Nord America 5.918
EU - Europa 3.573
AS - Asia 2.371
SA - Sud America 247
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 4
Totale 12.188
Nazione #
US - Stati Uniti d'America 5.873
IT - Italia 1.076
CN - Cina 892
SE - Svezia 830
SG - Singapore 634
UA - Ucraina 568
HK - Hong Kong 293
BR - Brasile 219
FI - Finlandia 209
TR - Turchia 186
RU - Federazione Russa 167
DE - Germania 157
KR - Corea 150
GB - Regno Unito 124
FR - Francia 123
IE - Irlanda 98
BG - Bulgaria 88
IN - India 59
VN - Vietnam 37
NL - Olanda 28
MY - Malesia 26
PL - Polonia 26
CA - Canada 25
BE - Belgio 24
JP - Giappone 21
EU - Europa 18
SN - Senegal 16
MX - Messico 15
BD - Bangladesh 14
ZA - Sudafrica 13
AR - Argentina 12
CH - Svizzera 11
ES - Italia 9
MA - Marocco 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
EC - Ecuador 6
IL - Israele 6
PK - Pakistan 6
RO - Romania 6
EG - Egitto 5
ID - Indonesia 5
IR - Iran 5
CL - Cile 4
DK - Danimarca 4
GR - Grecia 4
IQ - Iraq 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LV - Lettonia 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
ET - Etiopia 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GN - Guinea 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LT - Lituania 1
MW - Malawi 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TL - Timor Orientale 1
UG - Uganda 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.188
Città #
Ann Arbor 786
Woodbridge 655
Chandler 495
Jacksonville 491
Houston 429
Ashburn 389
Trieste 340
Fairfield 334
Hong Kong 287
Singapore 286
Hefei 278
Wilmington 269
Beijing 255
Izmir 179
Princeton 165
Seoul 149
Boardman 138
Dallas 134
Seattle 131
Columbus 104
Dublin 98
Dearborn 92
Milan 89
Sofia 88
Cambridge 83
Los Angeles 81
Moscow 56
Buffalo 55
The Dalles 39
Helsinki 37
Bremen 33
Santa Clara 33
Des Moines 32
San Diego 31
Jinan 28
Frankfurt am Main 27
Verona 25
Brussels 24
Düsseldorf 24
Redwood City 23
Nanjing 21
Ho Chi Minh City 20
Chicago 19
Grafing 19
Tokyo 19
São Paulo 18
Catania 17
New York 17
Shanghai 17
Warsaw 17
Dakar 16
Munich 16
Washington 16
Norwalk 15
Phoenix 15
Guangzhou 14
Brooklyn 13
Mestre 13
London 11
Rome 11
Shenyang 11
Kunming 10
Mumbai 10
Denver 9
Falkenstein 9
Falls Church 9
Fremont 9
Padova 9
Rio de Janeiro 9
Zhengzhou 9
Bern 8
Chennai 8
Johannesburg 8
Lauterbourg 8
Messina 8
Portsmouth 8
Redondo Beach 8
Toronto 8
Turin 8
Turku 8
Urbino 8
Andover 7
Baku 7
Krasnoyarsk 7
Naples 7
Palermo 7
Tianjin 7
Belo Horizonte 6
Brescia 6
Buseto Palizzolo 6
Casablanca 6
Fuzhou 6
Hanoi 6
Hebei 6
Manchester 6
Montreal 6
Nanchang 6
North Bergen 6
Perugia 6
Pisa 6
Totale 7.918
Nome #
Analisi Farmaceutica Qualitativa 438
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations 275
A 3D-Pharmacophore Model for σ2 Receptors Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives 262
Improving selectivity preserving affinity: New piperidine-4-carboxamide derivatives as effective sigma-1-ligands 253
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 229
Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. 222
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 220
Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands 215
Antihypertensive activity of arylidenaminoguanidine derivatives. 205
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 202
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands 201
Another Brick in the Wall. Validation of the σ1Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1Ligands 192
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site 190
Potential antihypertensive agents. IV. Aminoguanidine and hydrazinopyrimidine derivatives. 181
In-vitro antimycobacterial activity of new synthetic amidrazone derivatives 178
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma1 receptor ligand based on a series of benzo[d]oxazol-2(3H)-one derivatives 174
Synthesis and antihypertensive activity of some aminoguanidine and amidrazone derivatives 171
Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives 170
null 168
Synthesis and antifungal activity of (9/)-1-(5-aryl-3-pyridin-2-yl-4,5-dihydro-pyrazol-1-yl)-2-imidazol-1-yl-ethanone derivatives. 167
Antimycobacterial activities of N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones. 162
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 160
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 159
Esteri solfonici di aminoalcoli di potenziale interesse farmacologico. 157
Ion-pair liquid chromatographic assay of angiotensin-converting enzyme activity 155
Synthesis and antibacterial activity of aminoguanidine and amidrazone derivatives 155
Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives 153
Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor 151
Antihypertensive activity of some 1,3,4-tiadiazole derivatives. 150
Antitubercular activity of a new pyridinecarboxamidrazone compound alone and in combination with reference drugs, by MRA and in a macrophage model. 149
A simple high-performance liquid chromatographic method for estimation of human serum angiotensin converting enzyme activity. 148
Simultaneous quantitation of paracetamol, caffeine and propyphenazone by high-pressure liquid chromatography 147
Determinazione di aminofenazone e procaina in una forma farmaceutica mediante HPLC. 132
Overview on σ1 receptor: a 3D homology model to solve a part of the enigma. 130
Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones 128
Potenziali antivirali. Nota XII. Glicidesteri. 128
Fusaric acid derivatives and analogues as possible antihypertensive agents. Note III. 123
1-substituted-3-(o-aminoalkyl)-1H-indole derivatives as possible sigma ligands. 123
Synthesis and antifungal activity of some amidrazone derivatives 121
2-Aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds. Convetional heating in comparison with MW-assisted synthesis. 120
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. 120
Synthesis and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives 119
Design, synthesis and biological profile of new piperidine-4-carboxamide as effective sigma ligands 113
3-Piperidin-4-yl-methyl-3H-benzoxazol-2-one derivatives as sigma ligands. 113
null 109
Substituted benzylaminoalkylindoles with preference for the σ2 binding site 108
The sigma-enigma. A multistep homology modeling of sigma1 receptors 107
Synthesis and antimycobacterial activity of 1,3,4-oxadiazol-2-one derivatives 107
Determinazione quantitativa della carbamazepina nelle compresse mediante HPLC in fase inversa. 106
Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives 105
Simultaneous determination of amiodarone and desethylamiodarone in human plasma by high-pressure liquid chromatography. 105
"Sintesi ed attività antimicobatterica di derivati 2-piridincarbossamidrazonici di 1-[4-(1H-imidazol-1-il)fenil]-3-arilpropanonni." 105
Preliminary evaluation of in-vitro antimycobacterial properties of N1-(aryliden)-2-pyridincarboxamidrazones 104
Benzoxazinones and correlated scaffolds linked to benzylamino moieties through a butylene spacer. New sigma receptor ligands 104
null 103
Simultaneous determination of phenobarbital, phenytoin and methylphenobarbital in tablet formulations by HPLC 102
Synthesis and antimycobacterial activity of 5-aryl-1-isonicotynoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives. 101
null 101
Synthesis and antimycobacterial activity of some indole derivatives of pyridine-2-carboxamidrazone and quinoline-2-carboxamidrazone 99
High-pressure liquid chromatographic analysis of paracetamol, caffeine and acetylsalicylic acid in tablets. Salicylic acid quantitation 99
Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4-thiadiazole derivatives 99
Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives 95
Chemioterapici antivirali. Nota XIX. Derivati adamantanici e vari. 95
null 93
null 91
Guida al corso di Esercitazioni di Chimica Farmaceutica e Tossicologica II (Analisi Quantitativa) 89
Determinazone di propifenazone in una forma farmaceutica mediante HPLC. 88
null 88
A new class of substituted benzo[d]oxazole-2(3H)-one derivatives as sigma1 ligands. 88
Progettazione e sintesi di nuovi derivati bis-imidazolici ad attività antifungina ed antimicobatterica 88
Sulla Sintesi di Potenziali B-bloccanti. 87
Saggio limite per l'iminodibenzile nelle compresse di carbamazepina 86
Rapporti fra costituzione chimica e sapore dolce. Nota XV. Derivati L-acilamidosuccinanilici. 84
Benzossazol-2-oni e benzotiazol-2-oni come possibili ligandi sigma. 84
Attività antitubercolare in-vitro di composti di nuova sintesi, derivati del piridincarbossamidrazone, su sei specie di Mycobacterium e su ventidue ceppi di M. tuberculosis di isolamento ospedaliero 83
SYNTHESIS, MOLECULAR MODELING AND EXPERIMENTALACTIVITY OF SOME NEW ACETAMIDE, BENZAMIDE ANDPHENYLMETHANONE DERIVATIVES AS SIGMA LIGANDS. 82
Quantitative high-pressure liquid chromatographic determination of guanabenz and mephruside in pharmaceutical formulations 80
Attività analgesica dell'ester 2-dimetilaminoetilico dell'acido p-etossibenzensolfonico. 80
null 80
Determinazione quantitativa di aminofenazone e clortenossazina in una forma farmaceutica mediante HPLC. 78
Determinazione quantitativa della clortenossazina mediante HPLC. 78
null 78
Molecular modeling in drug design. New chemicals with antibacterial, antitubercular and antifungal activity: synthesis and MIC evaluatiotn. Experimental and computational approach. 78
Guida al corso di Esercitazioni di Chimica Farmaceutica e Tossicologica II (Analisi Quantitativa) 77
null 73
null 72
null 70
null 70
null 66
null 65
null 65
Synthesis and antimycobacterial activity of 1,3,4-oxadiazol-2-one derivatives. 58
The sigma enigma. 3D homology modeling, computer-assisted drug design, 3D pharmacophore-guided docking, MM/PBSA scoring, in silico/in vitro alanine scanning mutagenesis, and functional assay to unveil the sigma-1 receptor hidden secrets. 55
null 54
null 53
Synthesis and antifungal activity of new N-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-1-ethylidene]-N'-phenylhydrazine derivatives. 48
Synthesis and antimycobacterial activity of 1,3,4-oxadiazol-2-one derivatives. 45
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives. 44
null 43
Risoluzione di ligandi selettivi sigma1 a struttura alchilamminoalchilarilica mediante HPLC chirale e studio configurazionale. 43
Totale 12.267
Categoria #
all - tutte 36.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021800 0 0 0 0 64 124 68 114 126 132 51 121
2021/20221.265 51 102 81 248 19 116 75 50 134 107 75 207
2022/20231.664 128 164 112 201 182 321 9 130 174 148 64 31
2023/2024828 59 44 77 44 113 70 110 139 17 41 79 35
2024/20251.531 29 17 45 130 152 209 55 102 216 171 202 203
2025/20261.571 388 288 456 369 70 0 0 0 0 0 0 0
Totale 12.429